Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: A possible role of a novel death domain protein MADD in TNF- α-induced ERK1/2 activation in Kaposi's sarcoma cells

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3672-3679

  Murakami Mori, Kaoru ^a   Mori, Shunsuke ^a   Bonavida, Benjamin ^a   Nakamura, Shuji ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DACTINOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; INFLAMMATORY DISEASE; KAPOSI SARCOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CELL DIVISION; DACTINOMYCIN; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; GROWTH INHIBITORS; GROWTH SUBSTANCES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SARCOMA, KAPOSI; THREONINE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 0033559866     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Friedman-Kien, A. E., L. J. Laubenstein, P. Rubinstein, E. Buimovici-Klein, M. Marmor, R. Stahl, I. Spigland, K. S. Kim, and S. Zolla-Pazner. 1982. Disseminated Kaposi's sarcoma in homosexual men. Ann. Intern. Med. 96:693.
2. Gottlieb, G. J., and A. B. Ackerman. 1982. Kaposi's sarcoma: an extensively disseminated form in young homosexual men. Hum. Pathol. 13:882.
3. Ruszczak, Z., A. Mayer-Da Silva, and C. E. Orfanos. 1987. Kaposi's sarcoma in AIDS: multicentric angioneoplasia in early skin lesions. Am. J. Dermatopathol. 9:388.
4. Regezi, J. A., L. A. MacPhail, T. E. Daniels, Y. G. DeSouza, J. S. Greenspan, and D. Greenspan. 1993. HIV-associated oral Kaposi's sarcoma: a heterogeneous cell population dominated by spindle-shaped endothelial cells. Am. J. Pathol. 143: 240.
5. Penn, I. 1979. Kaposi's sarcoma in organ transplant recipients. Transplantation 27:8.
6. Ensoli, B., G. Barillari, and R. C. Gallo. 1991. Pathogenesis of AIDS-associated Kaposi's sarcoma. Hematol. Oncol. Clin. N. Am. 5:281.
7. Miles, S. A. 1994. Pathogenesis of HIV-related Kaposi's sarcoma. Curr. Opin. Oncol. 6:497.
8. Ensoli, B., S. Nakamura, S. Z. Salahuddin, P. Biberfeld, L. Larsson, B. Beaver, F. Wong-Staal, and R. C. Gallo. 1989. AIDS Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223.
9. Corbeil, J., L. A. Evans, E. Vasak, D. A. Cooper, and R. Penny. 1991. Culture and properties of cells derived from Kaposi sarcoma. J. Immunol. 146:2972.
10. Ensoli, B., P. Markham, V. Kao, G. Barillari, V. Fiorelli, R. Gendelman, M. Raffeld, G. Zon, and R. C. Gallo. 1994. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor: a novel strategy for the therapy of KS. J. Clin. Invest. 94:1736.
11. Cornali, E., C. Zietz, R. Benelli, W. Weninger, L. Masiello, G. Breier, E. Tschachler, A. Albini, and M. Stürzl. 1996. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am. J. Pathol. 149:1851.
12. Nakamura, S., K. Murakami-Mori, N. Rao, H. A. Weich, and B. Rajeev. 1997. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells. J. Immunol. 158:4992.
13. + T cells. Science 242:426.
14. Miles, S. A., O. Martinez-Maza, A. Rezai, L. Magpantay, T. Kishimoto, S. Nakamura, S. F. Radka, and P. S. Linsley. 1992. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255:1432.
15. Murakami-Mori, K., T. Taga, T. Kishimoto, and S. Nakamura. 1996. The soluble form of the IL-6 receptor (sIL-6Rα) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells: the soluble form of gp130 is antagonistic for sIL-6Rα-induced AIDS-KS cell growth. Int. Immunol. 8:595.
16. Murakami-Mori, K., S. Mori, T. Taga, T. Kishimoto, and S. Nakamura. 1997. Enhancement of gp130-mediated tyrosine phosphorylation of Stat3 and its DNA binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation. J. Immunol. 158:5518.
17. Samaniego, F., P. D. Markham, R. C. Gallo, and B. Ensoli. 1995. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J. Immunol. 154:3582.
18. Samaniego, F., P. D. Markham, R. Gendelman, Y. Watanabe, V. Kao, K. Kowalski, J. A. Sonnabend, A. Pintus, R. C. Gallo, and B. Ensoli. 1998. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am. J. Pathol. 152: 1433.
19. Aggarwal, B. B., and K. Natarajan. 1996. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:93.
20. Molina, J-M., D. T. Scadden, R. Byrn, C. A. Dinarello, and J. E. Groopman. 1989. Production of tumor necrosis factor a and interleukin 1β by monocytic cells infected with human immunodeficiency virus. J. Clin. Invest. 84:733
21. Merrill, J. E., Y. Koyanagi, and I. S. Y. Chen. 1989. Interleukin-1 and tumor necrosis factor α can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 63:4404.
22. Lähdevirta, J., C. P. J. Maury, A.-M. Teppo, and H. Repo. 1988. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:289.
23. Oxholm, A., P. Oxholm, H. Permin, and K. Bendtzen. 1989. Epidermal tumor necrosis factor α and interleukin 6-like activities in AIDS-related Kaposi's sarcoma: an immunohistological study. APMIS 97:533.
24. Aboulafia, D., S. A. Miles, S. R. Saks, and R. T. Mitsuyasu. 1989. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. J. Acquired Immune Defic. Syndr. 2:54.
25. Murakami-Mori, K., S. Mori, and S. Nakamura. 1998. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals. J. Immunol. 161:1694.
26. Tartaglia, L. A., and D. V. Goeddel. 1992. Two TNF receptors. Immunol. Today 13:151.
27. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5:392.
28. Moriguchi, T., Y. Gotoh, and E. Nishida. 1996. Roles of the MAP kinase cascade in vertebrates. Adv. Pharmacol. 36:121.
29. Vietor, I., P. Schwenger, W. Li, J. Schlessinger, and J. Vilcek. 1993. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J. Biol. Chem. 268: 18994.
30. Raines, M. A., R. N. Kolesnick, and D. W. Golde. 1993. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J. Biol. Chem. 268:14572.
31. Rafiee, P., J. K. Lee, C.-C. Leung, and T. A. Raffin. 1995. TNFα induces tyrosine phosphorylation of mitogen-activated protein kinase in adherent human neutrophils. J. Immunol. 154:4785.
32. mapk/crk2 following engagement of tumor necrosis factor receptor CD120a (p55) in mouse macrophages. J. Immunol. 155:1525.
33. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
34. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305.
35. Schievella, A. R., J. H. Chen, J. R. Graham, and L.-L. Lin. 1997. MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 272:12069.
36. Murakami-Mori, K., T. Taga, T. Kishimoto, and S. Nakamura. 1995. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor: complete block of OM-induced KS cell growth and OM binding by anti-gp130 Abs. J. Clin. Invest. 96:1319.
37. Payne, D. M. A. J. Rossomando, P. Martino, A. K. Erickson, J.-H. Her, J. Shabanowitz, D. F. Hunt, M. J. Weber, and T. W. Sturgill. 1991. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10:885.
38. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381.
39. Zheng, C.-F., and K.-L. Guan. 1993. Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases. MEK1 and MEK2. J. Biol. Chem. 268:11435.
40. Zheng, C-F., and K.-L. Guan. 1993. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases. J. Biol. Chem. 268:23933.
41. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
42. Hsu, H., J. Xiong, and D. V. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495.
43. Hsu, H., J. Huang, H.-B. Shu, V. Baichwal, and D. V. Goeddel. 1996. TNF dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4:387.
44. Hsu, H., H.-B. Shu, M.-G. Pan, and D. V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299.
45. Mori, S., K. Murakami-Mori, A. Jewett, S. Nakamura, and B. Bonavida. 1996. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Cancer Res. 56:1874.
46. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynolds, M. A. Palladino, Jr., and D. V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88:9292.
47. Tartaglia, L. A., D. V. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendly, and M. A. Palladino, Jr. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151:4637.
48. Mackay, F., J. Rothe, H. Bluethmann, H. Loetscher, and W. Lesslauer. 1994. Differential responses of fibroblasts from wild-type and TNFR55-deficient mice to mouse and human TNF-α activation. J. Immunol. 153:5274.
49. Naume, B., R. Shalaby, W. Lesslauer, and T. Espevik. 1991. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. J. Immunol. 146:3045.
50. Gehr, G., R. Gentz, M. Brockhaus, H. Loetscher, and W. Lesslauer. 1992. Both tumor necrosis factor receptor types mediate proliferative signals in human immonuclear cell activation. J. Immunol. 149:911.
51. Liu, R. Y., C. Fan, S. Mitchell, Q. Chen, J. Wu, and K. S. Zuckerman. 1998. The role of type I and type II tumor necrosis factor (TNF) receptors in the ability of TNFα to transduce a proliferative signal in the human megakaryoblastic leukeinic cell line Mo7e. Cancer Res. 58:2217.
52. Tartaglia, L. A., D. Pennica, and D. V. Goeddel. 1993. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268:18542.
53. MAPK/ ERK-2 in Kaposi's cells: evidence that this pathway is important in Kaposi cell growth. J. Clin. Invest. 92:848.
54. Dionne, S., I. D. D'Agata, F. M. Ruemmele, E. Levy, J. St-Louis, A. K. Srivastava, D. Levesque, and E. G. Seidman. 1998. Tyrosine kinase and MAPK inhibition of TNFα and EGF-stimulated ICE-6 cell growth. Biochem. Biophys. Res. Commun. 242:146.
55. Liu, Z.-G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565.
56. Cobb, M. H., and E. J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270:14843.
57. Marais, R., and C. J. Marshall. 1996. Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv. 27:101.
58. Brown, T. L., and P. H. Howe. 1998. MADD is highly homologous to a Rab3 guanidine-nucleotide exchange protein (Rab3-GEP). Curr. Biol. 8:R191.
59. Karp, J. E., J. M. Pluda, and R. Yarchoan. 1996. AIDS-related Kaposi's sarcoma: a template for the translation of molecular pathogenesis into targeted therapeutic approaches. Hematol. Oncol. Clin. North Am. 10:1031.
60. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865.
61. Decker, L. L. P. Shankar, G. Khan, R. B. Freeman, B. J. Dezube, J. Lieberman, and D. A. Thorley-Lawson. 1996. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J. Exp. Med. 184:283.
62. Blasig, C., C. Zietz, B. Haar, F. Neipel, S. Esser, N. H. Brockmeyer, E. Tschachler, S. Colombini, B. Ensoli, and M. Stürzl. 1997. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71: 7963.